The results from this investigation revealed that benzylidene-substituted pyrazolo3,4-bpyridine derivatives are potential anticancer agents that could be developed as potential anticancer drug candidates by inhibiting PIM-1 kinase activity.
Singh et al. (Thu,) studied this question.